{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T07:19:36Z","timestamp":1778915976585,"version":"3.51.4"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,3,14]],"date-time":"2019-03-14T00:00:00Z","timestamp":1552521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,3,14]],"date-time":"2019-03-14T00:00:00Z","timestamp":1552521600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Steven &amp; Alexandra Cohen Foundation"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Lyme disease (LD) is the most common tick-borne illness in the United States. Although appropriate antibiotic treatment is effective for most cases, up to 20% of patients develop post-treatment Lyme disease syndrome (PTLDS). There is an urgent need to improve clinical management of LD using precise understanding of disease and patient stratification. We applied machine-learning to electronic medical records to better characterize the heterogeneity of LD and developed predictive models for identifying medications that are associated with risks of subsequent comorbidities. For broad disease categories, we identified 3, 16, and 17 comorbidities within 2, 5, and 10 years of diagnosis, respectively. At a higher resolution of ICD-9 codes, we identified known associations with LD including chronic pain and cognitive disorders, as well as particular comorbidities on a timescale that matched PTLDS symptomology. We identified 7, 30, and 35 medications associated with risks of these comorbidities within 2, 5, and 10 years, respectively. For instance, the first-line antibiotic doxycycline exhibited a consistently protective association for typical symptoms of LD, including backache. Our approach and findings may suggest new hypotheses for more personalized treatments regimens for LD patients.<\/jats:p>","DOI":"10.1038\/s41598-019-41128-x","type":"journal-article","created":{"date-parts":[[2019,3,14]],"date-time":"2019-03-14T12:06:06Z","timestamp":1552565166000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Lyme Disease Patient Trajectories Learned from Electronic Medical Data for Stratification of Disease Risk and Therapeutic Response"],"prefix":"10.1038","volume":"9","author":[{"given":"Osamu","family":"Ichikawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin S.","family":"Glicksberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas","family":"Genes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2110-1145","authenticated-orcid":false,"given":"Brian A.","family":"Kidd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joel T.","family":"Dudley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,3,14]]},"reference":[{"key":"41128_CR1","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1001\/jama.2013.278331","volume":"310","author":"BM Kuehn","year":"2013","unstructured":"Kuehn, B. M. CDC estimates 300,000 US cases of Lyme disease annually. JAMA 310, 1110, https:\/\/doi.org\/10.1001\/jama.2013.278331 (2013).","journal-title":"JAMA"},{"key":"41128_CR2","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.3201\/eid2109.150417","volume":"21","author":"CA Nelson","year":"2015","unstructured":"Nelson, C. A. et al. Incidence of Clinician-Diagnosed Lyme Disease, United States, 2005\u20132010. Emerg Infect Dis 21, 1625\u20131631, https:\/\/doi.org\/10.3201\/eid2109.150417 (2015).","journal-title":"Emerg Infect Dis"},{"key":"41128_CR3","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1056\/NEJM200107123450207","volume":"345","author":"AC Steere","year":"2001","unstructured":"Steere, A. C. Lyme disease. N Engl J Med 345, 115\u2013125, https:\/\/doi.org\/10.1056\/NEJM200107123450207 (2001).","journal-title":"N Engl J Med"},{"key":"41128_CR4","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1056\/NEJMcp1314325","volume":"370","author":"ED Shapiro","year":"2014","unstructured":"Shapiro, E. D. Clinical practice. Lyme disease. N Engl J Med 370, 1724\u20131731, https:\/\/doi.org\/10.1056\/NEJMcp1314325 (2014).","journal-title":"Lyme disease. N Engl J Med"},{"key":"41128_CR5","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1086\/592279","volume":"198","author":"GP Wormser","year":"2008","unstructured":"Wormser, G. P. et al. Borrelia burgdorferi genotype predicts the capacity for hematogenous dissemination during early Lyme disease. J Infect Dis 198, 1358\u20131364, https:\/\/doi.org\/10.1086\/592279 (2008).","journal-title":"J Infect Dis"},{"key":"41128_CR6","doi-asserted-by":"publisher","first-page":"e73066","DOI":"10.1371\/journal.pone.0073066","volume":"8","author":"K Hanincova","year":"2013","unstructured":"Hanincova, K. et al. Multilocus sequence typing of Borrelia burgdorferi suggests existence of lineages with differential pathogenic properties in humans. PLoS One 8, e73066, https:\/\/doi.org\/10.1371\/journal.pone.0073066 (2013).","journal-title":"PLoS One"},{"key":"41128_CR7","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1038\/nrneurol.2015.121","volume":"11","author":"U Koedel","year":"2015","unstructured":"Koedel, U., Fingerle, V. & Pfister, H. W. Lyme neuroborreliosis-epidemiology, diagnosis and management. Nat Rev Neurol 11, 446\u2013456, https:\/\/doi.org\/10.1038\/nrneurol.2015.121 (2015).","journal-title":"Nat Rev Neurol"},{"key":"41128_CR8","doi-asserted-by":"publisher","first-page":"721","DOI":"10.2106\/JBJS.14.01331","volume":"98","author":"KD Baldwin","year":"2016","unstructured":"Baldwin, K. D., Brusalis, C. M., Nduaguba, A. M. & Sankar, W. N. Predictive Factors for Differentiating Between Septic Arthritis and Lyme Disease of the Knee in Children. J Bone Joint Surg Am 98, 721\u2013728, https:\/\/doi.org\/10.2106\/JBJS.14.01331 (2016).","journal-title":"J Bone Joint Surg Am"},{"key":"41128_CR9","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1086\/508667","volume":"43","author":"GP Wormser","year":"2006","unstructured":"Wormser, G. P. et al. The clinical assessment, treatment, and prevention of lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis 43, 1089\u20131134, https:\/\/doi.org\/10.1086\/508667 (2006).","journal-title":"Clin Infect Dis"},{"key":"41128_CR10","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1056\/NEJMra072023","volume":"357","author":"HM Feder Jr.","year":"2007","unstructured":"Feder, H. M. Jr. et al. A critical appraisal of \u201cchronic Lyme disease\u201d. N Engl J Med 357, 1422\u20131430, https:\/\/doi.org\/10.1056\/NEJMra072023 (2007).","journal-title":"N Engl J Med"},{"key":"41128_CR11","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1212\/01.WNL.0000291407.40667.69","volume":"70","author":"JJ Halperin","year":"2008","unstructured":"Halperin, J. J. Prolonged Lyme disease treatment: enough is enough. Neurology 70, 986\u2013987, https:\/\/doi.org\/10.1212\/01.WNL.0000291407.40667.69 (2008).","journal-title":"Neurology"},{"key":"41128_CR12","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1086\/318138","volume":"31","author":"R Patel","year":"2000","unstructured":"Patel, R., Grogg, K. L., Edwards, W. D., Wright, A. J. & Schwenk, N. M. Death from inappropriate therapy for Lyme disease. Clin Infect Dis 31, 1107\u20131109, https:\/\/doi.org\/10.1086\/318138 (2000).","journal-title":"Clin Infect Dis"},{"key":"41128_CR13","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1056\/NEJM200107123450202","volume":"345","author":"MS Klempner","year":"2001","unstructured":"Klempner, M. S. et al. Two controlled trials of antibiotic treatment in patients with persistent symptoms and a history of Lyme disease. N Engl J Med 345, 85\u201392, https:\/\/doi.org\/10.1056\/NEJM200107123450202 (2001).","journal-title":"N Engl J Med"},{"key":"41128_CR14","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1212\/01.WNL.0000284604.61160.2d","volume":"70","author":"BA Fallon","year":"2008","unstructured":"Fallon, B. A. et al. A randomized, placebo-controlled trial of repeated IV antibiotic therapy for Lyme encephalopathy. Neurology 70, 992\u20131003, https:\/\/doi.org\/10.1212\/01.WNL.0000284604.61160.2d (2008).","journal-title":"Neurology"},{"key":"41128_CR15","doi-asserted-by":"publisher","first-page":"e84758","DOI":"10.1371\/journal.pone.0084758","volume":"9","author":"C Finch","year":"2014","unstructured":"Finch, C. et al. Integrated assessment of behavioral and environmental risk factors for Lyme disease infection on Block Island, Rhode Island. PLoS One 9, e84758, https:\/\/doi.org\/10.1371\/journal.pone.0084758 (2014).","journal-title":"PLoS One"},{"key":"41128_CR16","doi-asserted-by":"publisher","first-page":"289","DOI":"10.3201\/eid0803.010166","volume":"8","author":"M Guerra","year":"2002","unstructured":"Guerra, M. et al. Predicting the risk of Lyme disease: habitat suitability for Ixodes scapularis in the north central United States. Emerg Infect Dis 8, 289\u2013297, https:\/\/doi.org\/10.3201\/eid0803.010166 (2002).","journal-title":"Emerg Infect Dis"},{"key":"41128_CR17","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1093\/infdis\/174.4.747","volume":"174","author":"MT Cantorna","year":"1996","unstructured":"Cantorna, M. T. & Hayes, C. E. Vitamin A deficiency exacerbates murine Lyme arthritis. J Infect Dis 174, 747\u2013751 (1996).","journal-title":"J Infect Dis"},{"key":"41128_CR18","first-page":"287","volume":"16","author":"V Cristea","year":"2003","unstructured":"Cristea, V. & Crisan, M. Lyme disease with magnesium deficiency. Magnes Res 16, 287\u2013289 (2003).","journal-title":"Magnes Res"},{"key":"41128_CR19","doi-asserted-by":"publisher","first-page":"67","DOI":"10.3109\/09273949709085052","volume":"5","author":"LD Ormerod","year":"1997","unstructured":"Ormerod, L. D., Puklin, J. E. & Giles, C. L. Chronic Propionibacterium acnes endophthalmitis as a cause of intermediate uveitis. Ocul Immunol Inflamm 5, 67\u201368 (1997).","journal-title":"Ocul Immunol Inflamm"},{"key":"41128_CR20","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1136\/bjophthalmol-2013-304589","volume":"98","author":"C Heinz","year":"2014","unstructured":"Heinz, C., Schoonbrood, S. & Heiligenhaus, A. Intermediate uveitis in children and young adults: differences in clinical course, associations and visual outcome. Br J Ophthalmol 98, 1107\u20131111, https:\/\/doi.org\/10.1136\/bjophthalmol-2013-304589 (2014).","journal-title":"Br J Ophthalmol"},{"key":"41128_CR21","doi-asserted-by":"publisher","first-page":"5491","DOI":"10.1073\/pnas.1502561112","volume":"112","author":"A Toledo","year":"2015","unstructured":"Toledo, A., Monzon, J. D., Coleman, J. L., Garcia-Monco, J. C. & Benach, J. L. Hypercholesterolemia and ApoE deficiency result in severe infection with Lyme disease and relapsing-fever Borrelia. Proc Natl Acad Sci USA 112, 5491\u20135496, https:\/\/doi.org\/10.1073\/pnas.1502561112 (2015).","journal-title":"Proc Natl Acad Sci USA"},{"key":"41128_CR22","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1016\/j.ophtha.2008.12.001","volume":"116","author":"JJ Wang","year":"2009","unstructured":"Wang, J. J. et al. Use of inhaled and oral corticosteroids and the long-term risk of cataract. Ophthalmology 116, 652\u2013657, https:\/\/doi.org\/10.1016\/j.ophtha.2008.12.001 (2009).","journal-title":"Ophthalmology"},{"key":"41128_CR23","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1111\/joim.12629","volume":"282","author":"A Pottegard","year":"2017","unstructured":"Pottegard, A. et al. Hydrochlorothiazide use is strongly associated with risk of lip cancer. J Intern Med 282, 322\u2013331, https:\/\/doi.org\/10.1111\/joim.12629 (2017).","journal-title":"J Intern Med"},{"key":"41128_CR24","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1007\/s10552-009-9375-2","volume":"20","author":"GD Friedman","year":"2009","unstructured":"Friedman, G. D., Udaltsova, N., Chan, J., Quesenberry, C. P. Jr. & Habel, L. A. Screening pharmaceuticals for possible carcinogenic effects: initial positive results for drugs not previously screened. Cancer Causes Control 20, 1821\u20131835, https:\/\/doi.org\/10.1007\/s10552-009-9375-2 (2009).","journal-title":"Cancer Causes Control"},{"key":"41128_CR25","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s11739-014-1157-5","volume":"10","author":"M Niafar","year":"2015","unstructured":"Niafar, M., Hai, F., Porhomayon, J. & Nader, N. D. The role of metformin on vitamin B12 deficiency: a meta-analysis review. Intern Emerg Med 10, 93\u2013102, https:\/\/doi.org\/10.1007\/s11739-014-1157-5 (2015).","journal-title":"Intern Emerg Med"},{"key":"41128_CR26","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1177\/2042098613482484","volume":"4","author":"JJ Heidelbaugh","year":"2013","unstructured":"Heidelbaugh, J. J. Proton pump inhibitors and risk of vitamin and mineral deficiency: evidence and clinical implications. Ther Adv Drug Saf 4, 125\u2013133, https:\/\/doi.org\/10.1177\/2042098613482484 (2013).","journal-title":"Ther Adv Drug Saf"},{"key":"41128_CR27","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1086\/315340","volume":"181","author":"RK Straubinger","year":"2000","unstructured":"Straubinger, R. K., Straubinger, A. F., Summers, B. A. & Jacobson, R. H. Status of Borrelia burgdorferi infection after antibiotic treatment and the effects of corticosteroids: An experimental study. J Infect Dis 181, 1069\u20131081, https:\/\/doi.org\/10.1086\/315340 (2000).","journal-title":"J Infect Dis"},{"key":"41128_CR28","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1002\/lary.26273","volume":"127","author":"N Jowett","year":"2017","unstructured":"Jowett, N., Gaudin, R. A., Banks, C. A. & Hadlock, T. A. Steroid use in Lyme disease-associated facial palsy is associated with worse long-term outcomes. Laryngoscope 127, 1451\u20131458, https:\/\/doi.org\/10.1002\/lary.26273 (2017).","journal-title":"Laryngoscope"},{"key":"41128_CR29","doi-asserted-by":"publisher","first-page":"193","DOI":"10.2165\/11531490-000000000-00000","volume":"27","author":"R Stahlmann","year":"2010","unstructured":"Stahlmann, R. & Lode, H. Safety considerations of fluoroquinolones in the elderly: an update. Drugs Aging 27, 193\u2013209, https:\/\/doi.org\/10.2165\/11531490-000000000-00000 (2010).","journal-title":"Drugs Aging"},{"key":"41128_CR30","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1097\/RHU.0b013e3181a7b0d4","volume":"15","author":"S Gultuna","year":"2009","unstructured":"Gultuna, S. et al. Ciprofloxacin induced tendinitis. J Clin Rheumatol 15, 201\u2013202, https:\/\/doi.org\/10.1097\/RHU.0b013e3181a7b0d4 (2009).","journal-title":"J Clin Rheumatol"},{"key":"41128_CR31","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/msb.2009.98","volume":"6","author":"M Kuhn","year":"2010","unstructured":"Kuhn, M., Campillos, M., Letunic, I., Jensen, L. J. & Bork, P. A side effect resource to capture phenotypic effects of drugs. Mol Syst Biol 6, 343, https:\/\/doi.org\/10.1038\/msb.2009.98 (2010).","journal-title":"Mol Syst Biol"},{"key":"41128_CR32","doi-asserted-by":"publisher","first-page":"D1075","DOI":"10.1093\/nar\/gkv1075","volume":"44","author":"M Kuhn","year":"2016","unstructured":"Kuhn, M., Letunic, I., Jensen, L. J. & Bork, P. The SIDER database of drugs and side effects. Nucleic Acids Res 44, D1075\u20131079, https:\/\/doi.org\/10.1093\/nar\/gkv1075 (2016).","journal-title":"Nucleic Acids Res"},{"key":"41128_CR33","doi-asserted-by":"publisher","first-page":"140","DOI":"10.2174\/1874205X01206010140","volume":"6","author":"ST Donta","year":"2012","unstructured":"Donta, S. T. Issues in the diagnosis and treatment of lyme disease. Open Neurol J 6, 140\u2013145, https:\/\/doi.org\/10.2174\/1874205X01206010140 (2012).","journal-title":"Open Neurol J"},{"key":"41128_CR34","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1136\/jnnp.2004.046284","volume":"76","author":"RA Abbott","year":"2005","unstructured":"Abbott, R. A., Hammans, S., Margarson, M. & Aji, B. M. Diaphragmatic paralysis and respiratory failure as a complication of Lyme disease. J Neurol Neurosurg Psychiatry 76, 1306\u20131307, https:\/\/doi.org\/10.1136\/jnnp.2004.046284 (2005).","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"41128_CR35","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1136\/bmj.326.7390.641","volume":"326","author":"J Lochhead","year":"2003","unstructured":"Lochhead, J. & Elston, J. S. Doxycycline induced intracranial hypertension. BMJ 326, 641\u2013642, https:\/\/doi.org\/10.1136\/bmj.326.7390.641 (2003).","journal-title":"BMJ"},{"key":"41128_CR36","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.humpath.2017.02.011","volume":"66","author":"K Affolter","year":"2017","unstructured":"Affolter, K., Samowitz, W., Boynton, K. & Kelly, E. D. Doxycycline-induced gastrointestinal injury. Hum Pathol 66, 212\u2013215, https:\/\/doi.org\/10.1016\/j.humpath.2017.02.011 (2017).","journal-title":"Hum Pathol"},{"key":"41128_CR37","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1093\/cid\/cir464","volume":"53","author":"JA Branda","year":"2011","unstructured":"Branda, J. A., Linskey, K., Kim, Y. A., Steere, A. C. & Ferraro, M. J. Two-tiered antibody testing for Lyme disease with use of 2 enzyme immunoassays, a whole-cell sonicate enzyme immunoassay followed by a VlsE C6 peptide enzyme immunoassay. Clin Infect Dis 53, 541\u2013547, https:\/\/doi.org\/10.1093\/cid\/cir464 (2011).","journal-title":"Clin Infect Dis"},{"key":"41128_CR38","doi-asserted-by":"crossref","unstructured":"Tibshirani, R. Regression shrinkage and selection via the lasso. Journal of the Royal Statistical Society. Series B (Methodological), 267\u2013288 (1996).","DOI":"10.1111\/j.2517-6161.1996.tb02080.x"},{"key":"41128_CR39","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1214\/08-AOS625","volume":"37","author":"H Zou","year":"2009","unstructured":"Zou, H. & Zhang, H. H. On the Adaptive Elastic-Net with a Diverging Number of Parameters. Ann Stat 37, 1733\u20131751, https:\/\/doi.org\/10.1214\/08-AOS625 (2009).","journal-title":"Ann Stat"},{"key":"41128_CR40","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1198\/016214501753382273","volume":"96","author":"J Fan","year":"2001","unstructured":"Fan, J. & Li, R. Variable selection via nonconcave penalized likelihood and its oracle properties. Journal of the American statistical Association 96, 1348\u20131360 (2001).","journal-title":"Journal of the American statistical Association"},{"key":"41128_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v033.i01","volume":"33","author":"J Friedman","year":"2010","unstructured":"Friedman, J., Hastie, T. & Tibshirani, R. Regularization Paths for Generalized Linear Models via Coordinate Descent. J Stat Softw 33, 1\u201322 (2010).","journal-title":"J Stat Softw"},{"key":"41128_CR42","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1146\/annurev.publhealth.21.1.121","volume":"21","author":"RJ Little","year":"2000","unstructured":"Little, R. J. & Rubin, D. B. Causal effects in clinical and epidemiological studies via potential outcomes: concepts and analytical approaches. Annu Rev Public Health 21, 121\u2013145, https:\/\/doi.org\/10.1146\/annurev.publhealth.21.1.121 (2000).","journal-title":"Annu Rev Public Health"},{"key":"41128_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v042.i08","volume":"42","author":"DE Ho","year":"2011","unstructured":"Ho, D. E., Imai, K., King, G. & Stuart, E. A. MatchIt: nonparametric preprocessing for parametric causal inference. Journal of Statistical Software 42, 1\u201328 (2011).","journal-title":"Journal of Statistical Software"},{"key":"41128_CR44","first-page":"1448","volume":"2013","author":"WQ Wei","year":"2013","unstructured":"Wei, W. Q., Mosley, J. D., Bastarache, L. & Denny, J. C. Validation and enhancement of a computable medication indication resource (MEDI) using a large practice-based dataset. AMIA Annu Symp Proc 2013, 1448\u20131456 (2013).","journal-title":"AMIA Annu Symp Proc"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-41128-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-41128-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-41128-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T07:40:22Z","timestamp":1671262822000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-41128-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,14]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["41128"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-41128-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,14]]},"assertion":[{"value":"16 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Dr. Dudley has received consulting fees or honoraria from Janssen Pharmaceuticals, GlaxoSmithKline, AstraZeneca, and Hoffman-La Roche; is a scientific advisor to LAM Therapeutics; and holds equity in NuMedii Inc., Ayasdi Inc., and Ontomics, Inc. Dr. Ichikawa is an employee of Sumitomo Dainippon Pharma Co., Ltd. The rest of authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"4460"}}